Brief: AFT Pharmaceuticals Says Annual Operating Revenue Up 15.2% To NZ$130.3 Million

AFT Pharmaceuticals

22/05/2022 21:55

May 23 (Reuters) - AFT Pharmaceuticals Ltd  AFT.NZ :
    * ANNUAL OPERATING REVENUE UP 15.2% TO NZ$130.3 MILLION
    * TARGETING OPERATING PROFIT RANGE FOR YEAR TO 31 MARCH 2023
OF
BETWEEN NZ$27 MILLION AND NZ$32 MILLION
    * FY NET PROFIT AFTER TAX NZ$19.8 MILLION VERSUS NZ$7.8
MILLION
    * INTENTION TO PAY DIVIDEND IN RELATION TO 2023 FY IN 20-30%
RANGE
OF NORMALISED NET PROFIT AFTER TAX

Source text for Eikon:  ID: 
Further company coverage:  AFT.NZ